Iron Deficiency Anemia and Non-iron Deficiency Anemia in Pregnancy in India
IDA & NIDA
Iron-deficiency and Non-iron-deficiency Anemia in Pregnancy and Infant Health in India
1 other identifier
observational
200
1 country
1
Brief Summary
This is a sub-study nested into the existing NICHD Global Network for Women's \& Children's Health Research Maternal Newborn Health (MNH) registry that is a prospective, observational population-based registry in Eastern Maharashtra, India. This study will assess the prevalence of iron deficiency anemia (IDA) and non-iron deficiency anemia (NIDA) in Eastern Maharashtra and will assess the association between both conditions and neo-natal and infant health outcomes (birth weight, gestational age at birth, weight-for-gestational-age z-score and infant hemoglobin concentration at 6 weeks). The investigators will also assess the relative strength of the association between anemia in the 1st trimester and 3rd trimester (after iron needs have increased but mothers may have been taking iron folic acid (IFA) supplements for several months) and infant health outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 23, 2020
CompletedFirst Submitted
Initial submission to the registry
January 8, 2021
CompletedFirst Posted
Study publicly available on registry
January 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2022
CompletedAugust 6, 2024
August 1, 2024
1.2 years
January 8, 2021
August 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Birthweight
0-48 hours
Secondary Outcomes (3)
gestational age at birth
<48 hours
weight-for-gestational-age z-score
<48 hours
infant hemoglobin at 6 weeks
6 weeks
Eligibility Criteria
200 pregnant women and their infants in Eastern Maharashtra, India. Mothers will be enrolled in the first trimester of pregnancy and mothers and infants will be followed up until 6 weeks post-partum.
You may qualify if:
- A pregnant women in the first trimester of pregnancy
- Enrolled in the Maternal \& Newborn Health Registry
- At least 18 years of age
- Residing in the area of a selected Primary Health Center with the intention to remain in the area through child birth and 6-weeks post-partum
You may not qualify if:
- Having multiple fetuses
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lata Medical Research Foundation
Nagpur, Maharashtra, India
Biospecimen
Venous blood will be drawn from pregnant women to assess iron status, hemoglobin, and inflammation. Hemoglobin will be assessed with a heel prick in infants and a finger prick in women.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lindsey M Locks, ScD MPH
Boston University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 8, 2021
First Posted
January 14, 2021
Study Start
November 23, 2020
Primary Completion
January 31, 2022
Study Completion
January 31, 2022
Last Updated
August 6, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share